Retraction: Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP (Carcinogenesis (2006) 27:10 (2018-2027) DOI: 10.1093/carcin/bgl043);Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 2018-2027

  Mantena, Sudheer K ^a   Sharma, Som D ^a   Katiyar, Santosh K ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BERBERINE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLINE; ISOQUINOLINE ALKALOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL XL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; WESTERN BLOTTING;

EID: 33748924524     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgy028     Document Type: Erratum

References (42)

1. O'Shaughnessy,J.A., Kelloff,G.J., Gordon,G.B. et al. (2002) Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Recommendations of the American Association for Cancer Research task force on the treatment and prevention of intraepithelial neoplasia. Clin. Cancer Res., 8, 314-346.
2. Housman,T.S., Feldman,S.R., Williford,P.M., Fleischer,A.B. Jr, Goldman,N.D., Acostamadiedo,J.M. and Chen,G.J. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol., 48, 425-429.
3. Naylor,M.F., Boyd,A., Smith,D.W., Cameron,G.S., Hubbard,D. and Neldner,K.H. (1995) High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch. Dermatol., 131, 170-175.
4. Craig,W.J. (1997) Phytochemicals: Guardians of our health. J. Am. Diet Assoc., 97, S199-S204.
5. Craig,W.J. (1999) Health-promoting properties of common herbs. Am. J. Clin. Nutr., 70, S491-S499.
6. Sathyavathi,G.V., Gupta,A.K. and Tandon,N. (1987) Medicinal plants of India. Spec. Rep. Ser. Indian Counc. Med. Res., 2, 230-239.
7. Takase,H., Yamamoto,K., Ito,K. and Yumioka,E. (1993) Pharmacological studies on antidiarrheal effects of berberine and geranin herb. Nippon Yakurigaku Zasshi, 2, 101-112.
8. Huang,W.M., Wu,Z.D. and Gan,Y.Q. (1989) Effects of berberine on ischemic ventricular arrhythmia. Zhonghua Xin Xue Guan Bing Za Zhi, 5, 300-301.
9. Fukuda,K., Hibiya,Y., Mutoh,M., Koshiji,M., Akao,S. and Fujiwarw,H. (1999) Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med., 65, 381-383.
10. Fukuda,K., Hibiya,Y., Mutoh,M., Koshiji,M., Akao,S. and Fujiwarw,H. (1999) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol, 2, 227-233.
11. Iizuka,N., Miyamoto,K., Okita,K., Tangoku,A., Hayashi,H. and Yosino,S. (2000) Inhibitory effect of coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett., 148, 19-25.
12. Lin,J.G., Chung,J.G. and Wu,L.T. (1999) Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am. J. Chin. Med., 27, 265-275.
13. Nishino,H., Kitagawa,K., Fujiki,H. and Iwashima,A. (1986) Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology, 43, 131-134.
14. Wang,L.-K., Rogers,B.D. and Hecht,S.M. (1996) Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne. Chem. Res. Toxicol., 9, 75-83.
15. Kim,S.A., Kwon,Y., Kim,J.H., Muller,M.T. and Chung,I.K. (1998) Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid,berberrubine. Biochemistry, 37, 16316-16324.
16. Liu,L.F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-375.
17. Roy,A.M., Baliga,M.S., Elmets,C.A. and Katiyar,S.K. (2005) Grape seed proanthocyanidins induce apoptosis through p53,Bax,and capsase-3 pathways. Neoplasia, 7, 24-36.
18. Liu,X., Kim,C.N., Yang,J., Jemmerson,R. and Wang,X. (1996) Induction of apoptotic program in cell free extracts: Requirement for dATP and cytochrome c. Cell, 86, 147-157.
19. Pavletich,N.P. (1999) Mechanisms of cyclin-dependent kinase regulation: structures of cdks,their cyclin activators,and CIP and INK4 inhibitors. J. Mol. Biol., 287, 821-828.
20. Ortega,S., Malumbres,M. and Barbacid,M. (2002) Cyclin D-dependent kinases,INK4 inhibitors and cancer. Biochim. Biophys. Acta, 1602, 73-87.
21. Morgan,D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
22. Fischer,P.M. (2001) Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors. Curr. Opin. Drug Discov. Devel., 4, 623-634.
23. Reed,J.C. (1995) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7, 541-546.
24. Adams,J.M. and Cory,S. (2001) Life-or-death decisions by the Bcl-2 protein family. Trends Biochem. Sci., 26, 61-66.
25. Chao,D.T. and Korsemeyer,S.J. (1998) Bcl-2 family: Regulators of cell death. Ann. Rev. Immunol., 16, 395-419.
26. Hockenbery,D., Nunez,G., Milliman,C., Schreiber,R.D. and Korsmeyer,S.J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
27. Wesierska-Gadek,J., Gueorguieva,M. and Horky,M. (2003) Dual action of cyclin-dependent kinase inhibitors: Induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin. Pol. J. Pharmacol., 55, 895-902.
28. Susin,S.A., Lorenzo,H.K., Zamzami,N. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factors. Nature, 397, 441-446.
29. Hengartner,M.O. (2000) The biochemistry of apoptosis. Nature, 407, 770-776.
30. Green,D.R. and Reed,J.C. (1998) Mitochondria and apoptosis. Science, 281, 1309-13012.
31. Thornberry,N.A. and Lazebnik,Y. (1998) Caspases: Enemies within. Science, 281, 1312-1316.
32. Wolf,B.B. and Green,D.R. (1999) Suicidal tendencies: Apoptotic cell death by caspase family proteinases. J. Biol. Chem., 274, 20049-20052.
33. Grana,X. and Reddy,P. (1995) Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKIs). Oncogene, 11, 211-219.
34. Kastan,M.B., Canman,C.E. and Leonard,C.J. (1995) P53, cell cycle control and apoptosis: Implications for cancer. Cancer Metastasis Rev., 14, 3-15.
35. Molinari,M. (2000) Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif., 33, 261-274.
36. Toyoshima,H. and Hunter,T. (1994) p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21. Cell, 78, 67-74.
37. Hunter,T. and Pine,J. (1994) Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
38. Pilat,M.J., Kamradt,J.M. and Pienta,K.J. (1998) Hormone resistance in prostate cancer. Cancer Metastasis, 17, 373-381.
39. Hickman,J.A. (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11, 121-139.
40. Gross,A., McDonnell,J.M. and Korsmeyer,S.J. (1999) Bcl-2 family members and the mitochondria in apoptosis. Genes Dev., 13, 1899-1911.
41. Crompton,M. (2000) Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr. Opin. Cell Biol., 12, 414-419.
42. Kluck,R.M., Bossy-Wetzel,E., Green,D.R. and Newmeyer,D.D. (1997) The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.